Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Boehringer Ingelheim
McKesson
Citi
AstraZeneca
Johnson and Johnson

Generated: April 20, 2019

DrugPatentWatch Database Preview

Brexpiprazole - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for brexpiprazole and what is the scope of brexpiprazole patent protection?

Brexpiprazole is the generic ingredient in one branded drug marketed by Otsuka Pharm Co Ltd and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Brexpiprazole has thirty-two patent family members in twenty-seven countries.

There are eight drug master file entries for brexpiprazole. One supplier is listed for this compound.

Summary for brexpiprazole
International Patents:32
US Patents:4
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 8
Suppliers / Packagers: 1
Bulk Api Vendors: 52
Clinical Trials: 51
Patent Applications: 76
DailyMed Link:brexpiprazole at DailyMed
Pharmacology for brexpiprazole
Synonyms for brexpiprazole
2(1H)-Quinolinone, 7-(4-(4-benzo(b)thien-4-yl-1-piperazinyl)butoxy)-
2J3YBM1K8C
7-(4-(4-(1-Benzothiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one
7-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one
7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]- 2(1H)-Quinolinone
7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)-butoxy]-1H-quinolin-2-one
7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one
7-[4-(4-Benzo[b]thiophen-4-ylpiperazin-1-yl)butoxy]-1H-quinolin-2-one
7-[4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one
913611-97-9
AC-30404
AK171366
AKOS025291100
AX8306230
BC600277
BCP10218
BCP24077
Brexpiprazole (JAN/USAN/INN)
Brexpiprazole [USAN:INN]
Brexpiprazole; OPC-34712
Brexpiprazole.2H2O
Brexpiprazole(OPC34712)
CHEBI:134716
CHEMBL2105760
CS-2108
D10309
DB09128
DTXSID40238527
EX-A2639
FT-0712292
GTPL7672
HY-15780
KS-0000063N
MolPort-039-063-477
MolPort-046-033-502
NCGC00378574-02
OPC 34712
OPC-34712
OPC34712
Rexulti
Rexulti (TN)
Rxulti
s4639
SB16735
SCHEMBL1037592
SCHEMBL14772509
UNII-2J3YBM1K8C
ZINC84758479
ZKIAIYBUSXZPLP-UHFFFAOYSA-N

US Patents and Regulatory Information for brexpiprazole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Otsuka Pharm Co Ltd REXULTI brexpiprazole TABLET;ORAL 205422-006 Jul 10, 2015 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Otsuka Pharm Co Ltd REXULTI brexpiprazole TABLET;ORAL 205422-005 Jul 10, 2015 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Otsuka Pharm Co Ltd REXULTI brexpiprazole TABLET;ORAL 205422-004 Jul 10, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Otsuka Pharm Co Ltd REXULTI brexpiprazole TABLET;ORAL 205422-005 Jul 10, 2015 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Otsuka Pharm Co Ltd REXULTI brexpiprazole TABLET;ORAL 205422-004 Jul 10, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for brexpiprazole

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1869025 LUC00086 Luxembourg ➤ Sign Up PRODUCT NAME: BREXPIPRAZOLE OU UN SEL DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/18/1294 20180730
1869025 300946 Netherlands ➤ Sign Up PRODUCT NAME: BREXPIPRAZOLE, DESGEWENST IN DE VORM VAN EEN ZOUT; REGISTRATION NO/DATE: EU/1/18/1294 20180727
1869025 PA2018509 Lithuania ➤ Sign Up PRODUCT NAME: BREKSPIPRAZOLAS ARBA JO DRUSKA; REGISTRATION NO/DATE: EU/1/18/1294 20180726
1869025 CA 2018 00028 Denmark ➤ Sign Up PRODUCT NAME: BREXPIPRAZOL ELLER ET SALT DERAF; REG. NO/DATE: EU/1/18/1294/001-006 20180727
1869025 2018C/037 Belgium ➤ Sign Up PRODUCT NAME: BREXPIPRAZOL OF EEN ZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: EU/1/18/1294 20180730
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Department of Justice
Mallinckrodt
Johnson and Johnson
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.